000 02239cam a2200289zu 4500
001 88930509
003 FRCYB88930509
005 20250107110006.0
006 m o d
007 cr un
008 250107s2022 fr | o|||||0|0|||eng d
020 _a9780128213988
035 _aFRCYB88930509
040 _aFR-PaCSA
_ben
_c
_erda
100 1 _aMachado-Vieira, Rodrigo
245 0 1 _aBiomarkers in Bipolar Disorders
_c['Machado-Vieira, Rodrigo', 'Soares, Jair']
264 1 _bElsevier Science
_c2022
300 _a p.
336 _btxt
_2rdacontent
337 _bc
_2rdamdedia
338 _bc
_2rdacarrier
650 0 _a
700 0 _aMachado-Vieira, Rodrigo
700 0 _aSoares, Jair
856 4 0 _2Cyberlibris
_uhttps://international.scholarvox.com/netsen/book/88930509
_qtext/html
_a
520 _aBiomarkers in Bipolar Disorders summarizes cutting-edge findings in biomarkers' research, emphasizing the most promising findings, tools and technologies relevant to drug development and personalized medicine. Key findings cover different levels of evidence such as genes, molecules, cells, systems, brain and behavior related to diagnosis (state and trait/endophenotypes), prediction of treatment response and follow-up outcomes, along with the most promising perspectives in each area. Each section includes a comprehensive and focused overview on the state-of-the-art and perspectives. The book concludes with a section on practical applications, encompassing diagnostics development (genetic testing, biomarkers), and new drug development. Edited by Dr. Rodrigo Machado-Vieira and Dr. Jair C. Soares, and contributed by leading experts in the field of biomarker research, this book will be become the leading tool for all researchers and clinicians in Bipolar Disorder. Describes strategies for the biomarker discovery of relevant proteins differentially expressed in Bipolar Disorder Presents techniques and main findings in transcriptome research related to CNS synaptic function Provides an overview on current behavioral strategies and their validity in drug development in Bipolar Disorder Discusses current genetic findings, integrating tests for treatments leading to personalized treatments
999 _c16450
_d16450